Corbus Pharmaceuticals Holdings, Inc. - CRBP

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Nov 13, 2026 SCHEDULE 13G MPM BioImpact LLC 8.6% 1,667,272 View
Nov 02, 2026 SCHEDULE 13G/A Cormorant Asset Management, LP 7.76% 1,500,000 View
Nov 02, 2026 SCHEDULE 13G/A Chen Bihua 7.76% 1,500,000 View
Oct 29, 2026 SCHEDULE 13G/A Aberdeen Group plc 0.0% 0 View
Oct 29, 2026 SCHEDULE 13G/A abrdn Inc. 0.0% 0 View
Sep 30, 2026 SCHEDULE 13G RA Capital Management, L.P. 9.9% 1,914,788 View
Sep 30, 2026 SCHEDULE 13G Peter Kolchinsky 9.9% 1,914,788 View
Sep 30, 2026 SCHEDULE 13G Rajeev Shah 9.9% 1,914,788 View
Sep 30, 2026 SCHEDULE 13G RA Capital Healthcare Fund, L.P. 9.9% 1,914,788 View
Aug 14, 2026 SCHEDULE 13G/A Citadel Advisors LLC 0.0% 0 View
Aug 14, 2026 SCHEDULE 13G/A Citadel Advisors Holdings LP 0.0% 0 View
Aug 14, 2026 SCHEDULE 13G/A Citadel GP LLC 0.0% 0 View
Aug 14, 2026 SCHEDULE 13G/A Citadel Securities LLC 1.1% 206,354 View
Aug 14, 2026 SCHEDULE 13G/A Citadel Securities Group LP 1.1% 206,354 View
Aug 14, 2026 SCHEDULE 13G/A Citadel Securities GP LLC 1.1% 206,354 View
Aug 14, 2026 SCHEDULE 13G/A Kenneth Griffin 1.1% 206,354 View
Jul 27, 2026 SCHEDULE 13G BlackRock, Inc. 5.9% 1,093,434 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.